Pantoprazole Hikma

Pantoprazole, the active ingredient in Pantoprazole Hikma, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults.

GNH USA supplies Pantoprazole Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare neuroendocrine tumor. - NSA‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation: occasional. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis: watery diarrhea, abdominal pain. - Acute interstitial nephritis: reduced urine output, swelling. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Fracture risk with long‑term use: bone pain, increased fracture susceptibility.

When prescribing Pantoprazole, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic function: use with caution in moderate to severe liver disease. - Review long‑term use: monitor for bone density loss and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Drug interactions: check for concomitant use of drugs that require gastric acidity for absorption. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption leading to therapeutic failure. - Atazanavir or nelfinavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Digoxin: slight increase in serum levels; observe for toxicity signs. - Methotrexate (high dose): reduced clearance; monitor renal function and drug levels.